Clinical trial
BHV-7000 Efficacy Against Epileptiform Activity in Patients With Epilepsy Implanted With RNS
NCT07125261 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BHV-7000 Efficacy Against Epileptiform Activity in Patients With Epilepsy Implanted With RNS
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- October 7, 2025
- Completion date
- September 30, 2026
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.